Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : PledPharma AB
Femme et Homme Max 99 ans
PledPharma AB
MAJ Il y a 4 ans
A local feasibility study of mangafodipir as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction
The main objective of the present trial is to find out whether mangafodipir, being a potent cardioprotective drug in animal studies, prevents reperfusion injury and reduces infarct size in patients du...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
PledPharma AB
MAJ Il y a 4 ans
A LOCAL FEASIBILITY STUDY ON MANGAFODIPIR AS AN ADJUNCT TO FOLFOX6 CHEMOTHERAPY IN PATIENTS OPERATED FOR COLORECTAL CANCER STAGE DUKE C (MANFOL)
The main objective of the present study is to find out whether pre-treatment with the compound mangafodipir lowers the frequency and/or severity of FOLFOX6-related haematological toxicity and neurosen...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
PledPharma AB
MAJ Il y a 4 ans
A Phase II Trial of PledOx in combination with the cancer theraphy FOLFOX6 in patients with cancer in the large inestine
Primary Objective Dose Escalation Phase: To characterize the prevalence, severity, drug-relatedness and seriousness of adverse events of PledOx in two doses Primary Objective Randomised Treatment Ph...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations